BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18973287)

  • 1. Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different.
    Hanson SM; Morlock EV; Satyshur KA; Czajkowski C
    J Med Chem; 2008 Nov; 51(22):7243-52. PubMed ID: 18973287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some insights into the binding mechanism of the GABAA receptor: a combined docking and MM-GBSA study.
    Xie HB; Sha Y; Wang J; Cheng MS
    J Mol Model; 2013 Dec; 19(12):5489-500. PubMed ID: 24241181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different residues in the GABAA receptor benzodiazepine binding pocket mediate benzodiazepine efficacy and binding.
    Morlock EV; Czajkowski C
    Mol Pharmacol; 2011 Jul; 80(1):14-22. PubMed ID: 21447642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural elements of the gamma-aminobutyric acid type A receptor conferring subtype selectivity for benzodiazepine site ligands.
    Renard S; Olivier A; Granger P; Avenet P; Graham D; Sevrin M; George P; Besnard F
    J Biol Chem; 1999 May; 274(19):13370-4. PubMed ID: 10224099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A (beta)-strand in the (gamma)2 subunit lines the benzodiazepine binding site of the GABA A receptor: structural rearrangements detected during channel gating.
    Teissére JA; Czajkowski C
    J Neurosci; 2001 Jul; 21(14):4977-86. PubMed ID: 11438573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural determinants for high-affinity zolpidem binding to GABA-A receptors.
    Sancar F; Ericksen SS; Kucken AM; Teissére JA; Czajkowski C
    Mol Pharmacol; 2007 Jan; 71(1):38-46. PubMed ID: 17012619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural mechanisms underlying benzodiazepine modulation of the GABA(A) receptor.
    Hanson SM; Czajkowski C
    J Neurosci; 2008 Mar; 28(13):3490-9. PubMed ID: 18367615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actions of two GABAA receptor benzodiazepine-site ligands that are mediated via non-γ2-dependent modulation.
    Leppä E; Linden AM; Rabe H; Vekovischeva OY; Wulff P; Lüddens H; Wisden W; Korpi ER
    Eur J Pharmacol; 2011 Sep; 666(1-3):111-21. PubMed ID: 21616065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modulation of synaptic GABA(A) receptors in the thalamus by eszopiclone and zolpidem.
    Jia F; Goldstein PA; Harrison NL
    J Pharmacol Exp Ther; 2009 Mar; 328(3):1000-6. PubMed ID: 19033556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of alphak/gamma2 (k=1, 2, 3 and 5) interface of GABA A receptor and docking studies with zolpidem: implications for selectivity.
    Ci SQ; Ren TR; Ma CX; Su ZG
    J Mol Graph Model; 2007 Sep; 26(2):537-45. PubMed ID: 17451983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the binding mode of Zolpidem to GABA(A) α₁ receptor - insights from molecular dynamics simulation.
    Vijayan RS; Bhattacharyya D; Ghoshal N
    J Mol Model; 2012 Apr; 18(4):1345-54. PubMed ID: 21748331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of amino acid residues responsible for the alpha5 subunit binding selectivity of L-655,708, a benzodiazepine binding site ligand at the GABA(A) receptor.
    Casula MA; Bromidge FA; Pillai GV; Wingrove PB; Martin K; Maubach K; Seabrook GR; Whiting PJ; Hadingham KL
    J Neurochem; 2001 Apr; 77(2):445-51. PubMed ID: 11299307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A point mutation in the gamma2 subunit of gamma-aminobutyric acid type A receptors results in altered benzodiazepine binding site specificity.
    Buhr A; Sigel E
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8824-9. PubMed ID: 9238062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative electroencephalography within sleep/wake states differentiates GABAA modulators eszopiclone and zolpidem from dual orexin receptor antagonists in rats.
    Neuropsychopharmacology; ; . PubMed ID: 23722242
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.